These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2103353)

  • 21. Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma.
    Niioka T; Uno T; Yasui-Furukori N; Takahata T; Shimizu M; Sugawara K; Tateishi T
    Cancer Chemother Pharmacol; 2007 Apr; 59(5):575-80. PubMed ID: 16912889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The French National Registry of HA-1A (Centoxin) in septic shock. A cohort study of 600 patients. The National Committee for the Evaluation of Centoxin.
    Arch Intern Med; 1994 Nov; 154(21):2484-91. PubMed ID: 7979845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-dose pharmacokinetics and safety of HA-1A, a human IgM anti-lipid-A monoclonal antibody, in pediatric patients with sepsis syndrome.
    Romano MJ; Kearns GL; Kaplan SL; Jacobs RF; Killian A; Bradley JS; Moss MM; Van Dyke R; Rodriguez W; Straube RC
    J Pediatr; 1993 Jun; 122(6):974-81. PubMed ID: 8501580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limited sampling models for amonafide (NSC 308847) pharmacokinetics.
    Ratain MJ; Staubus AE; Schilsky RL; Malspeis L
    Cancer Res; 1988 Jul; 48(14):4127-30. PubMed ID: 3383202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibodies for treatment of gram-negative infections.
    Young LS; Gascon R; Alam S; Bermudez LE
    Rev Infect Dis; 1989; 11 Suppl 7():S1564-71. PubMed ID: 2690294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Easy-to-use, accurate and flexible individualized Bayesian limited sampling method without fixed time points for ciclosporin monitoring after liver transplantation.
    Langers P; Cremers SC; den Hartigh J; Rijnbeek EM; Ringers J; Lamers CB; van Hoek B
    Aliment Pharmacol Ther; 2005 Mar; 21(5):549-57. PubMed ID: 15740538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotics enhance binding by human lipid A-reactive monoclonal antibody HA-1A to smooth gram-negative bacteria.
    Siegel SA; Evans ME; Pollack M; Leone AO; Kinney CS; Tam SH; Daddona PE
    Infect Immun; 1993 Feb; 61(2):512-9. PubMed ID: 8423081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of an optimal sampling strategy for clinical pharmacokinetic studies of the novel anthracycline disaccharide analogue MEN-10755.
    Bos AM; Boom K; Vinks AA; Boezen HM; Wanders J; Dombernovsky P; Aamdal S; de Vries EG; Uges DR
    Cancer Chemother Pharmacol; 2004 Jul; 54(1):64-70. PubMed ID: 15069581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive model of antimicrobial-resistant gram-negative bacteremia at the ED.
    Chiang WC; Chen SY; Chien KL; Wu GH; Yen AM; Su CP; Lee CC; Chen YC; Chang SC; Chen SC; Chen WJ; Chen TH
    Am J Emerg Med; 2007 Jul; 25(6):597-607. PubMed ID: 17606081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pharmacokinetic model for radioimmunotherapy delivered through cerebrospinal fluid for the treatment of leptomeningeal metastases.
    Lv Y; Cheung NK; Fu BM
    J Nucl Med; 2009 Aug; 50(8):1324-31. PubMed ID: 19617331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the Bayesian approach and a limited sampling model for the estimation of AUC and Cmax: a computer simulation analysis.
    Mahmood I; Miller R
    Int J Clin Pharmacol Ther; 1999 Sep; 37(9):439-45. PubMed ID: 10507242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibody therapy for gram-negative sepsis: principles, applications, and controversies.
    Mehra IV; Gottlieb JE; Nash DB
    Pharmacotherapy; 1993; 13(2):128-34. PubMed ID: 8469619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limited-sampling strategy for the prediction of boosted hard-gel saquinavir exposure at a dosage of 1000/100 mg twice daily in human immunodeficiency virus-infected individuals.
    Dickinson L; Back D; Pozniak A; Khoo S; Boffito M
    Ther Drug Monit; 2007 Jun; 29(3):361-7. PubMed ID: 17529895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antibodies to endotoxin in the management of sepsis.
    Fang KC
    West J Med; 1993 Apr; 158(4):393-9. PubMed ID: 8317126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The anti-lipid A antibody HA-1A binds to rough gram-negative bacteria, fixes complement and facilitates binding to erythrocyte CR1 (CD35).
    Tonoli M; Davies KA; Norsworthy PJ; Cohen J; Walport MJ
    Clin Exp Immunol; 1993 May; 92(2):232-8. PubMed ID: 8485908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of a protective human monoclonal for the treatment of gram-negative sepsis.
    Larrick JW; Gray O; Deinhart T; Wang J; Flatgaard J; Chong KT
    Prog Clin Biol Res; 1988; 272():383-93. PubMed ID: 3393571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Monoclonal anti-endotoxin antibodies in the treatment of patients with sepsis due to Gram-negative bacteria].
    Speelman P; van Deventer SJ
    Ned Tijdschr Geneeskd; 1991 May; 135(20):877-8. PubMed ID: 2046787
    [No Abstract]   [Full Text] [Related]  

  • 38. Mechanism for monoclonal antibody mediated treatment of gram-negative shock.
    Torensma R; Fluit A
    Lancet; 1991 Jul; 338(8760):186. PubMed ID: 1677084
    [No Abstract]   [Full Text] [Related]  

  • 39. Anti-lipid A monoclonal antibody centoxin (HA-1A) binds to a wide variety of hydrophobic ligands.
    Helmerhorst EJ; Maaskant JJ; Appelmelk BJ
    Infect Immun; 1998 Feb; 66(2):870-3. PubMed ID: 9453659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Criteria for use of antiendotoxin monoclonal antibodies (HA-1A and E5) in adult and pediatric inpatients.
    Shepherd MF
    Clin Pharm; 1992 Mar; 11(3):257-60. PubMed ID: 1611816
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.